U.S. Markets open in 58 mins.

AstraZeneca looks for alliance to share drug development costs, FT says

Reflecting the growing trend for drugmakers to share costs and risks of developing new drugs, AstraZeneca is considering a big strategic alliance with another pharmaceutical company to share the costs and benefits of experimental drug development, the Financial Times says.